Main > ONCOLOGY (**) > Lung>NSCLC>Squamous>MET> > TREAT.: > CN. I. PD-1 Binding MAb Inj.+

---

CN. I. PD-1 Binding MAb Inj.+'s subsections
(*) CN Approval Date: 2021. 06.03.
+Gemcitabine+Pt CT
Companies
Generic Name: Sintilimab
MAb: Monoclonal Antibody
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 06.01.
PD: Programmed cell Death
PR Web-Site
RTM

CN. I. PD-1 Binding MAb Inj.+'s products
This section has no products